Persistent airway inflammation and high exacerbation rate in asthma that starts at menopause

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 67, Issue 3, 2007, Pages 135-141

  Balzano, Giovanni ^a   Fuschillo, S ^a   De Angelis, E ^a   Gaudiosi, C ^a   Mancini, A ^b   Caputi, M ^b  

^a IRCCS   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Airway inflammation; Asthma; Asthma perception; Asthma severity; Menopause

Indexed keywords

AMOXICILLIN; ANTIASTHMATIC AGENT; BECLOMETASONE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PREDNISOLONE; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; ATOPY; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CHRONIC SINUSITIS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; DRUG USE; EOSINOPHIL COUNT; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HUMAN; HUMAN CELL; LUNG FUNCTION; MENOPAUSE; PATIENT MONITORING; RECURRENT DISEASE; RESPIRATORY TRACT INFLAMMATION; SPUTUM ANALYSIS; SYMPTOMATOLOGY;

EID: 35948964912     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2007.484     Document Type: Article

References (32)

1. Global strategy for asthma management and prevention. NIH Publication No. 02-3659, April 2002. http://www.ginasthma.com.
2. Balzano G, Fuschillo S, Melillo G, Bonini S. Asthma and sex hormones. Allergy 2001; 56: 13-20.
3. Kohler PO. Clinical endocrinology. New York: John Wiley & Sons; 1986.
4. Bonner JR. The epidemiology and natural history of asthma. Clin Chest Med 1983; 5: 557-65.
5. Durwood BJ. Concomitant problems with asthma. Ala J Med Sci 1985; 22: 393-5.
6. Myers JR, Sherman CB. Should supplemental estrogens be used as steroid-sparing agents in asthmatic women? Chest 1994; 106: 318-9.
7. Miranda T, Strand MS, Trudeau JB, Fisher SJ, Wenzel SE. Severe asthmatics with late onset disease have greater eosinophilic inflammation, airway obstruction and are less steroid responsive than early onset disease. Am J Respir Crit Care Med 2003; 167: A856.
8. Ten Briuke A, Ouwerkerck ME, Zwinderman AH, Spiuhoven P, Bel EH. Psychopathology in patients with severe asthma is associated with increased health care utilization. Am J Respir Crit Care Med 2001; 163: 1093-6.
9. American Thoracic Society. Standardization of Spirometry: 1994 Update. Official Statement. Am J Respir Crit Care Med 1995; 152: 1107-36.
10. 20 methacholine assessed by the dosimeter inhalation test. Chest 1989; 95: 1238-43.
11. Borg GAV. Psycho-physical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-81.
12. Boulet LP, Turcotte H, Cartier A, et al. Influence of beclomethasone and salmeterol on the perception of methacholine-induced bronchoconstriction. Chest 1998; 114: 373-9.
13. Balzano G, Stefanelli F, Iorio C, et al. Eosinophilic inflammation in stable chronic obstructive pulmonary disease. Relationship with neutrophils and airway function. Am J Respir Crit Care Med 1999; 160: 1486-92.
14. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. Lancet 1998; 351: 1225-32.
15. Tattersfield AE, Postma DS, Barnes PJ, et al. Exacerbations of asthma. A descriptive study of 425 severe exacerbations. Am J Respir Crit Care Med 1999; 160: 594-9.
16. Serra-Batlles J, Plaza V, Morejòn E, Comella A, Brugués J. Costs of asthma according to the degree of severity. Eur Respir J 1998; 12: 1322-6.
17. Barnes PJ, Woolcock AJ. Difficult asthma. Eur Respir J 1998; 12: 1209-18.
18. The ENFUMOSA Study Group. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 2003; 22: 470-7.
19. Dolan CM, Fraher KE, Bleecker ER, et al. Design and baseline characteristics of The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol 2004; 92: 32-9.
20. Robinson DS, Campbell DA, Durham SR, Pfeffer J, Barnes PJ, Chung KF. Systematic assessment of difficult-to-treat asthma. Eur Respir J 2003; 22: 478-83.
21. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airway inflammation and remodelling. Am J Respir Crit Care Med 2000; 161: 1720-45.
22. Louis R, Lau LCK, Bron AO, Roldaan AC, Radermecker M, Djukanovic R. The relationship between airway inflammation and asthma severity. Am J Respir Crit Care Med 2000; 161: 9-16.
23. Troisi RJ, Speizer FE, Willet MC, Trichopoulus D, Rosner B. Menopause, post-menopausal estrogen preparations and the risk of adult-onset asthma. Am J Respir Crit Care Med 1995; 152: 1183-8.
24. Collins LC, Peiris A. Bronchospasm secondary to replacement estrogen therapy. Chest 1993; 104: 1300-2.
25. Pizzichini E, Pizzichini MM, Efthimiadis A, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurement. Am J Respir Crit Care Med 1996; 154: 308-17.
26. Spanevello A, Confalonieri M, Sulotto, et al. Induced sputum cellularity. Reference values and distribution in normal volunteers. Am J Respir Crit Care Med 2000; 162: 1172-4.
27. Jatakanon A, Lim S, Chung KF, Barnes PJ. An inhaled steroid improves markers of airway inflammation in patients with mild asthma. Eur Respir J 1998; 12: 1084-8.
28. Lim S, Jatakanon A, John M, et al. Effect of inhaled budesonide on lung function and airway inflammation. Am J Respir Crit Care Med 1999; 159: 22-30.
29. Jatakanon A, Uasuf C, Maziak W, Lim S, Chung KF, Barnes PJ. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999; 160: 1532-9.
30. Douwes J, Gibson P, Pekkanen J, Pearce N. Noneosinophilic asthma: importance and possible mechanisms. Thorax 2002; 57: 643-8.
31. In't Veen JCCM, Smits HH, Ravensberg AJJ, Hiemstra PS, Sterk PJ, Bel EH. Impaired perception of dyspnea in patients with severe asthma. Relation to sputum eosinophils. Am J Respir Crit Care Med 1998; 158: 1134-41.
32. Pauwels RA, Lofdhal CG, Postma S, et al. Additive effects of inhaled formoterol and budesonide in reducing asthma exacerbations: a one-year, controlled study. N Engl J Med 1997; 337: 1405-11.